Monitor for any prospectus supplement announcing a takedown under the shelf, which would signal imminent dilution. Given the extreme disparity between shelf size and market cap, even a small percentage of the shelf being utilized could significantly dilute existing shareholders. The stock may trade under an overhang until the shelf expires or is fully utilized.
Price Chart
Executive Summary
Dermata Therapeutics' S-3 shelf registration (File No. 333-299391) was declared effective on October 20, 2026, enabling the company to offer up to $100 million in common stock, preferred stock, warrants, debt securities, subscription rights, or units from time to time. This creates a potential dilution overhang for the micro-cap biotech, which has a market cap of only ~$4M, as the shelf size is ~25x the current market cap.
Key Facts
- Shelf registration (S-3) declared effective on October 20, 2026 under File No. 333-299391
- Maximum aggregate offering amount is $100,000,000
- Securities may include common stock, preferred stock, warrants, debt securities, subscription rights, or units
- Company's market cap is approximately $4M, making the shelf size ~25x current market cap
- Common stock (DRMA) and warrants (DRMAW) are listed on Nasdaq
- Last reported common stock price as of May 21, 2026 was $1.24 per share
Financial Impact
Shelf registration of up to $100M represents potential dilution of ~25x current $4M market cap; any takedown would be highly dilutive
Risk Factors
- Potential for highly dilutive equity offerings given shelf size relative to market cap
- Micro-cap biotech with no approved products may need to raise capital, increasing likelihood of shelf utilization
- Warrant overhang (DRMAW) adds additional potential dilution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003304 |
| Document: 9999999995-26-003304-index.html | 9999999995-26-003304 |
| Document: 9999999995-26-003304.txt | 9999999995-26-003304 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 7d ago | EFFECT | $0.8000 $0.8640 | ▼ −8.00% | ▼ −9.18% | $0.7550 (+5.63%) |
Oct 9, 2026 18d ago | S-3 | $0.8896 $0.8599 | ▼ −3.34% | ▼ −3.33% | $0.7550 (−15.13%) |
Aug 17, 2026 10w ago | 8-K | $1.46 $1.43 | ▲ +2.05% | ▲ +1.38% | $0.7550 (+48.29%) |
Aug 5, 2026 11w ago | 8-K | $1.17 $1.11 | ▼ −5.13% | ▼ −4.97% | $0.7550 (−35.47%) |
Feb 25, 2026 34w ago | 8-K | $1.25 $1.20 | ▼ −4.00% | ▼ −3.52% | $0.7550 (−39.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers